Financials
Financial year 2025
DISTEPHAR from Zedelgem, company number BE0885857745, closed financial year 2025 with a result of € 67,795 after tax. For that financial year DISTEPHAR recorded a gross margin of € 296,030 and equity of € 223,444. Compared with financial year 2024, the result moved from € 56,385 to € 67,795. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.
€ 223,444
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 67,795
▲ 20% vs 2024
Profit after tax over the fiscal year.
€ 126,010
▼ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 59,000 paid out
87 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
1.9
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 157,652
▲ 17% vs 2024
€ 83,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 157,004
▼ 14% vs 2024
Of which on lease € 157,004.
Debts at end 2025
€ 174,235
▼ 17% vs 2024
€ 29,964 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 355,886
▲ 270% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 51,188
▲ 98% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 209,359 | € 252,473 | € 257,879 | € 296,030 | ▲ 15% |
| Profit after taxes | € 23,380 | € 61,861 | € 56,385 | € 67,795 | ▲ 20% |
| Equity | € 191,404 | € 204,265 | € 214,650 | € 223,444 | ▲ 4% |
| Total debts | € 727,008 | € 741,279 | € 506,592 | € 782,057 | ▲ 54% |
| Cash | € 312,802 | € 183,763 | € 153,386 | € 126,010 | ▼ 18% |
| Retained profit | € 111,932 | € 124,793 | € 135,177 | € 143,972 | ▲ 7% |
| Dividend | € 21,700 | € 49,000 | € 46,000 | € 59,000 | ▲ 28% |
| Bank debt | € 286,679 | € 247,889 | € 209,530 | € 174,235 | ▼ 17% |
| Balance sheet total | € 918,413 | € 945,544 | € 721,242 | € 1,005,501 | ▲ 39% |
| Employees (FTE) | 1.8 | 1.7 | 1.8 | 1.9 | ▲ 0.1 |
Key figures of DISTEPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DISTEPHAR?
What happened at DISTEPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 67,795 (▲ 20% vs 2024). filed late Source: NBB ↗
- New establishment in Zedelgem. KBO
- Start of the company according to the CBE. KBO
In short
From € 23,380 profit in 2022 to € 67,795 profit in 2025.
Paid € 21,492 in corporate taxes since 2022.
Best year ever: 2025, with € 67,795 profit.
On average € 155,800 of value added per employee in 2025.
A new publication or filing at DISTEPHAR? We notify you, reason included.
Follow DISTEPHARDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DISTEPHAR are MEULEMEESTER STEVEN BV and MEULEMEESTER DIDRIK BV. The same people are also behind STEDIPHAR, Farmadistri, Bobbie Pharmaceutical Services and FARMAZORG. MEULEMEESTER STEVEN BV is also behind MEDIPACK.
Directors
According to the 2025 annual accounts
Administrator-manager · represented by STEVEN MEULEMEESTER
Also active at: STEDIPHAR, Farmadistri, Bobbie Pharmaceutical Services, FARMAZORG, MEDIPACK
Administrator-manager · represented by DIDRIK WIM MEULEMEESTER
Also active at: STEDIPHAR, Farmadistri, Bobbie Pharmaceutical Services, FARMAZORG
Establishments
Establishment units
Physical locations of this company
Stationsstraat 7
8210 Zedelgem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
LEVEL27-AS * Please direct all complaints to [email protected] *, BE
Website info
Features
Security
Network
Details
- Company number
- 0885.857.745
- VAT number
- BE 0885.857.745
- Registered office
- Stationsstraat 7, 8210 Zedelgem
- Names & denominations
- DISTEPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2006
- Peppol
- Active · Active since 24 Jul 2025
- Contact
- apotheek-meulemeester.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers